1.
Kevin Gaffney, Michael Weinberg, Maira Soto, Stan Louie, Kathleen Rodgers. Development of angiotensin II (1-7) analog as an oral therapeutic for the treatment of chemotherapy-induced myelosuppression. Haematologica 2018;103(12):e567-e570; https://doi.org/10.3324/haematol.2018.193771.